My Bibliography

select

Puszkin S, Perry D, Li S, Hanson V. Neuronal protein NP185 is developmentally regulated, initially expressed during synaptogenesis, and localized in synaptic terminals. Mol Neurobiol. 1992 Summer-Fall;6(2-3):253-83. doi: 10.1007/BF02780557. Review. PubMed PMID: 1476676.

select

Perry DG, Li S, Hanson V, Puszkin S. Neuromuscular junctions contain NP185: the multifunctional protein is located at the presynaptic site. J Neurosci Res. 1992 Nov;33(3):408-17. doi: 10.1002/jnr.490330307. PubMed PMID: 1469744.

select

Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP. Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem. 1995 Jun 30;270(26):15693-701. doi: 10.1074/jbc.270.26.15693. PubMed PMID: 7797570.

select

Li S, Song KS, Lisanti MP. Expression and characterization of recombinant caveolin. Purification by polyhistidine tagging and cholesterol-dependent incorporation into defined lipid membranes. J Biol Chem. 1996 Jan 5;271(1):568-73. PubMed PMID: 8550621.

select

Li S, Seitz R, Lisanti MP. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. J Biol Chem. 1996 Feb 16;271(7):3863-8. PubMed PMID: 8632005.

select

Song KS, Li Shengwen, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem. 1996 Apr 19;271(16):9690-7. doi: 10.1074/jbc.271.16.9690. PubMed PMID: 8621645.

select

Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem. 1996 Jun 21;271(25):15160-5. doi: 10.1074/jbc.271.25.15160. PubMed PMID: 8663016.

select

Li S, Song KS, Koh SS, Kikuchi A, Lisanti MP. Baculovirus-based expression of mammalian caveolin in Sf21 insect cells. A model system for the biochemical and morphological study of caveolae biogenesis. J Biol Chem. 1996 Nov 8;271(45):28647-54. doi: 10.1074/jbc.271.45.28647. PubMed PMID: 8910498.

select

Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem. 1996 Nov 15;271(46):29182-90. doi: 10.1074/jbc.271.46.29182. PubMed PMID: 8910575; PubMed Central PMCID: PMC6687395.

select

Song KS, Tang Z, Li S, Lisanti MP. Mutational analysis of the properties of caveolin-1. A novel role for the C-terminal domain in mediating homo-typic caveolin-caveolin interactions. J Biol Chem. 1997 Feb 14;272(7):4398-403. doi: 10.1074/jbc.272.7.4398. PubMed PMID: 9020162.

select

Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997 Mar 7;272(10):6525-33. doi: 10.1074/jbc.272.10.6525. PubMed PMID: 9045678.

select

Couet J, Shengwen L, Okamoto T, Scherer PE, Lisanti MP. Molecular and cellular biology of caveolae paradoxes and plasticities. Trends Cardiovasc Med. 1997 May;7(4):103-10. doi: 10.1016/S1050-1738(97)00001-7. PubMed PMID: 21235872.

select

Puertollano R, Li S, Lisanti MP, Alonso MA. Recombinant expression of the MAL proteolipid, a component of glycolipid-enriched membrane microdomains, induces the formation of vesicular structures in insect cells. J Biol Chem. 1997 Jul 18;272(29):18311-5. doi: 10.1074/jbc.272.29.18311. PubMed PMID: 9218471.

select

García-Cardeña G, Martasek P, Masters BS, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem. 1997 Oct 10;272(41):25437-40. doi: 10.1074/jbc.272.41.25437. PubMed PMID: 9325253.

select

Lisanti MP, Li S, Tang ZL, Song KS, Kubler E, Scherer PE. Caveolin, an integral membrane protein of caveolae membranes in vivo: Implications for signal transduction. In: Lanier SM, Limbird LE, editors. beta2 Adrenergic Receptors: Structure, function and therapeutic implications London, United Kingdom: Harwood Academic Publishers, 1997. (ISBN 90-5702-019-X); 1997. 63-76p.

select

Li S, Galbiati F, Volonte D, Sargiacomo M, Engelman JA, Das K, Scherer PE, Lisanti MP. Mutational analysis of caveolin-induced vesicle formation. Expression of caveolin-1 recruits caveolin-2 to caveolae membranes. FEBS Lett. 1998 Aug 28;434(1-2):127-34. doi: 10.1016/s0014-5793(98)00945-4. PubMed PMID: 9738464.

select

Li S, Lisanti M, Puszkin S. Purification and molecular characterization of NP185, a neuronal-specific and synapse-enriched clathrin assembly polypeptide. Bioquim Patol Clin. 1998;62(1):5-17. PubMed PMID: 31402847; PubMed Central PMCID: PMC6688760.

select

Volonte D, Galbiati F, Li S, Nishiyama K, Okamoto T, Lisanti MP. Flotillins/cavatellins are differentially expressed in cells and tissues and form a hetero-oligomeric complex with caveolins in vivo. Characterization and epitope-mapping of a novel flotillin-1 monoclonal antibody probe. J Biol Chem. 1999 Apr 30;274(18):12702-9. doi: 10.1074/jbc.274.18.12702. PubMed PMID: 10212252.

select

Zhang L, Lin WJ, Li S, Aoki KR. Complete DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain. Gene. 2003 Oct 2;315:21-32. doi: 10.1016/s0378-1119(03)00792-3. PubMed PMID: 14557061.

select

Methods of modulating intracellular degradation rates of toxins. USPTO, USA 6,991,789. 2004.

select

Wang H, Haas M, Liang M, Cai T, Tian J, Li S, Xie Z. Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase. J Biol Chem. 2004 Apr 23;279(17):17250-9. doi: 10.1074/jbc.M313239200. Epub 2004 Feb 12. PubMed PMID: 14963033; NIHMSID:NIHMS1053938.

select

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=30&f=G&l=50&co1=AND&d=PG01&s1=Li-Shengwen.IN.&OS=IN/Li-Shengwen&RS=IN/Li-Shengwen, assignee. Rescue agents for treating botulinum toxin intoxications. USA - patent application United States Patent Application 20050106182. 2005.

select

Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeutics. USA - patent application United States Patent Application 20050169942. 2005.

select

METHODS OF MODULATING INTRACELLULAR DEGRADATION RATES OF TOXINS. USA - patent application United States Patent Application 20050287175. 2005.

select

Lipid rafts and clostridial toxins. USA - patent application United States Patent Application 20050129677. 2005.

select

Methods of modulating intracellular degradation rates of toxins. USA - patent application United States Patent Application 20060257430. 2006.

select

Novel methods for production of di-chain botulinum toxin. USA - patent application United States Patent Application 20060024794. 2006.

select

Li S, Kirov I, Klassen HJ, Schwartz PH. Characterization of Human Stem Cells Using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR). In: Loring,,J.,F., Wesselschmidt,,R.,L., Schwartz PH, editors. Human Stem Cell Manual: A Laboratory Guide Loudon, New York, Boston: Elsevier; 2006. Chapter 10. 127-149p.

select

Rescue agents for treating botulinum toxin intoxications. USA, USPTO 7,172,764. 2007.

select

Popov VM, Wang C, Shirley LA, Rosenberg A, Li S, Nevalainen M, Fu M, Pestell RG. The functional significance of nuclear receptor acetylation. Steroids. 2007 Feb;72(2):221-30. doi: 10.1016/j.steroids.2006.12.001. Epub 2007 Feb 7. Review. PubMed PMID: 17291555; PubMed Central PMCID: PMC2694494.

select

Ju X, Katiyar S, Wang C, Liu M, Jiao X, Li S, Zhou J, Turner J, Lisanti MP, Russell RG, Mueller SC, Ojeifo J, Chen WS, Hay N, Pestell RG. Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7438-43. doi: 10.1073/pnas.0605874104. Epub 2007 Apr 25. PubMed PMID: 17460049; PubMed Central PMCID: PMC1863437.

select

Powell M, Li S, Lisanti MP, Nevalainen M, Wang C, Pestell RG. Androgen receptor epigenetic modification and acetylation regulate prostate cellular growth.. In: Berns D, editor. Networks and Epigenetics in Prostate Cancer. London, New York, Boston: Elsevier 2007.; 2007. p.10.1007/978-1-60327-079-3. 147-161p.

select

Li SC, Loudon WG. Stem Cell Therapy for Paediatric Malignant Brain Tumours: The Silver Bullet?. Oncology News (United Kingdom of British), http://www.oncologynews.biz/pdf/jun_jul_08/ONJJ08_stemcell.pdf. 2008; 3(1 (June/July -2008)):10-15..

select

MODIFIED CLOSTRIDIAL TOXINS WITH ENHANCED TRANSLOCATION CAPABILITIES AND ALTERED TARGETING ACTIVITY FOR CLOSTRIDIAL TOXIN TARGET CELLS. USA - United States Patent Application 20080241881. 2008.

select

Optimizing Expression Of Active BotulinumToxin Type E. USA - United States Patent Application 20080138893. 2008.

select

Activatable Clostridial Toxins. USA- patent application United States Patent Application 20080161226. 2008.

select

Optimizing Expression of Active Botulinum Toxin Type A. USA- patent application United States Patent Application 20080057575A1. 2008.

select

ACTIVATABLE CLOSTRIDIAL TOXINS. USA - patent application United States Patent Application 20080032930. 2008.

select

Modified Clostridial Toxins With Altered Targeting Capabilities For Clostridial Toxin Target Cells. USA - patent application United States Patent Application 20080161543. 2008.

select

Tran N, Li S. Differential proteomic panning analysis of protein from serum and cultured stem cells: An alternative to mass spectrometric methods. The FASEB Journal. 2008; 22:lb248) © 2008 FASEB. 2008.

select

ACTIVATABLE CLOSTRIDIAL TOXINS. USA - patent application United States Patent Application 20080032931. 2008.

select

Su Q, Li S. Small activating mRNA (samRNA): A hypothesis for a specific positive feedback regulation of gene expression. Bioscience hypotheses. 2008; 1(1):44-47. doi: 10.1016/j.bihy.2008.01.007..

select

Tran N, Li S. Differential proteomic panning analysis of protein from serum and cultured stem cells: An alternative to mass spectrometric methods. The FASEB Journal. 2008; 22:lb248) © 2008 FASEB. 2008.

select

Modified Clostridial Toxins With Enhanced Targeting Capabilities For Endogenous Clostridial Toxin Receptor Systems. USA - patent application United States Patent Application 20080096248. 2008.

select

Li SC, Loudon WG. A novel and generalizable organotypic slice platform to evaluate stem cell potential for targeting pediatric brain tumors. Cancer Cell Int. 2008 May 22;8:9. doi: 10.1186/1475-2867-8-9. PubMed PMID: 18498656; PubMed Central PMCID: PMC2474582.

select

Li S. Stem Cell Therapy for Paediatric Malignant tumors: The Silver Bullet?. Oncology News, England, U.K.. 2008 June; 3(1):10-15.

select

Li SC, Wang L, Jiang H, Acevedo J, Chang AC, Loudon WG. Stem cell engineering for treatment of heart diseases: potentials and challenges. Cell Biol Int. 2009 Mar;33(3):255-67. doi: 10.1016/j.cellbi.2008.11.009. Epub 2008 Dec 3. Review. PubMed PMID: 19084605.

select

ACTIVATABLE CLOSTRIDIAL TOXINS. USA - patent application United States Patent Application 20090004224. 2009.

select

ACTIVATABLE CLOSTRIDIAL TOXINS. USA - patent application United States Patent Application 20090005313. 2009.

select

MULTIVALENT CLOSTRIDIAL TOXINS. USA - patent application United States Patent Application 20090048431. 2009.